
-
Oil industry presence surges at UN plastic talks: NGOs
-
Kipyegon says a woman will run a sub-four minute mile
-
Tokyo soars on trade deal relief as most Asian markets limp into weekend
-
Israel to 'take control' of Gaza City after approving new war plan
-
Australian A-League side Western United stripped of licence
-
'Back home': family who fled front buried after Kyiv strike
-
Indonesia cracks down on pirate protest flag
-
Israeli army will 'take control' of Gaza City: PM's office
-
Australian mushroom murderer accused of poisoning husband
-
Coventry's mettle tested by Russian Olympic debate, say former IOC figures
-
Library user borrows rare Chinese artwork, returns fakes: US officials
-
Parisians hot under the collar over A/C in apartments
-
Crypto group reportedly says it planned sex toy tosses at WNBA games
-
American Shelton tops Khachanov to win first ATP Masters title in Toronto
-
Tokyo soars on trade deal relief as Asian markets limp into weekend
-
New species teem in Cambodia's threatened karst
-
Australian mushroom murderer accused of poisoning husband: police
-
Solid gold, royal missives and Nobel noms: how to win Trump over
-
Canadian teen Mboko outlasts Osaka to win WTA Montreal crown
-
Trump to host Armenia, Azerbaijan for historic 'Peace Signing'
-
Israeli airline's Paris offices daubed with red paint, slogans
-
US raises bounty on Venezuela's Maduro to $50 mn
-
Lebanon cabinet meets again on Hezbollah disarmament
-
Bolivia right-wing presidential hopeful vows 'radical change'
-
Trump says would meet Putin without Zelensky sit-down
-
Trump offers data to justify firing of labor stats chief
-
Bhatia leads by one at PGA St. Jude, Scheffler five adrift
-
Disney settles Trump-supporting 'Star Wars' actor lawsuit
-
Trump moves to kill $7 billion in solar panel grants
-
Venus Williams falls at first hurdle in Cincinnati
-
Mixed day for global stocks as latest Trump levies take effect
-
SpaceX agrees to take Italian experiments to Mars
-
US judge orders temporary halt to new 'Alligator Alcatraz' construction
-
US uses war rhetoric, Superman to recruit for migrant crackdown
-
US to rewrite its past national climate reports
-
U can't pay this: MC Hammer sued over delinquent car loan
-
WHO says nearly 100,000 struck with cholera in Sudan
-
Huge wildfire in southern France now under control
-
Kane scores as Bayern thump Spurs in pre-season friendly
-
France strikes down return of banned bee-killing pesticide
-
Canada sends troops to eastern province as fire damage grows
-
OpenAI releases ChatGPT-5 as AI race accelerates
-
Plastic pollution treaty talks deadlocked
-
A French sailor's personal 'Plastic Odyssey'
-
Netanyahu says Israel to control not govern Gaza
-
Partey signs for Villarreal while on bail for rape charges
-
Wales have the talent to rise again, says rugby head coach Tandy
-
US partners seek relief as Trump tariffs upend global trade
-
Five England players nominated for women's Ballon d'Or
-
PSG dominate list of men's Ballon D'Or nominees
RBGPF | -5.79% | 71.84 | $ | |
RYCEF | -0.42% | 14.44 | $ | |
CMSC | 0.04% | 22.96 | $ | |
NGG | -0.31% | 72.08 | $ | |
RELX | 1.03% | 49.32 | $ | |
AZN | 1.3% | 74.57 | $ | |
BP | 0.91% | 34.19 | $ | |
GSK | 2.21% | 37.58 | $ | |
RIO | 1.12% | 60.77 | $ | |
BTI | 0.51% | 56.69 | $ | |
SCU | 0% | 12.72 | $ | |
VOD | -0.36% | 11.26 | $ | |
SCS | 0.06% | 16 | $ | |
BCC | 0.32% | 83.19 | $ | |
CMSD | -0.09% | 23.52 | $ | |
JRI | 0.52% | 13.41 | $ | |
BCE | 2.23% | 23.78 | $ |

US pharmacy chains announce abortion pill rollout
America's two biggest pharmacy chains said Friday they will begin dispensing prescription abortion pills in a limited number of states where it's legal.
The move greatly broadens availability of the drug mifepristone, even as a legal case over whether it was properly approved two decades ago now rests before the Supreme Court.
Walgreens "expects to begin dispensing within a week" in New York, Pennsylvania, Massachusetts, California, and Illinois, the company said on its website.
"But in the interests of pharmacist and patient safety, we will not disclose the number of sites per state nor identify the pharmacies that are dispensing," it added.
A CVS spokesperson told AFP: "We'll begin filling prescriptions for the medication in Massachusetts and Rhode Island in the weeks ahead and will expand to additional states, where allowed by law, on a rolling basis."
The Food and Drug Administration (FDA) authorized pharmacies to carry mifepristone in January 2023, with Friday's announcements the results of a long certification process.
Mifepristone works to block a pregnancy, while a second drug, misoprostol, provokes bleeding to empty the uterus and was already widely available in pharmacies.
The news was hailed by President Joe Biden, who has made protecting reproductive rights a key part of his re-election campaign against the likely Republican candidate Donald Trump.
Trump tipped the balance of the Supreme Court during his own presidency and paved the way for reversal of the national right to abortion.
"With major retail pharmacy chains newly certified to dispense medication abortion, many women will soon have the option to pick up their prescription at a local, certified pharmacy -- just as they would for any other medication," Biden said in a statement.
"The stakes could not be higher for women across America. In the face of relentless attacks on reproductive freedom by Republican elected officials, Vice President Harris and I will continue to fight to ensure that women can get the health care they need."
The US Supreme Court overturned the nationwide right to abortion in 2022, allowing each state to pass its own laws governing the procedure.
Twenty-one states have since banned or moved to restrict abortions to limits tighter than before Roe v Wade, the previous case that upheld the constitutional right to terminate a pregnancy.
Abortion pills remain illegal in states where the procedure is prohibited. But women who decide to travel to a state where abortion is legal may now find a pharmacy much closer than an abortion clinic, reducing their travel.
The Supreme Court will hear arguments March 26 in a case brought by anti-abortion groups to restrict access to mifepristone, first approved in the year 2000 and used by more than 5.6 million Americans since.
R.Kloeti--VB